FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022158208> ?p ?o ?g. }

• W2022158208 endingPage "2921" @default.
• W2022158208 startingPage "2912" @default.
• W2022158208 abstract "Abstract BACKGROUND: Although many patients with chronic myeloid leukemia (CML) respond well to imatinib therapy, a significant proportion loses their initial response. Loss of response on imatinib is often because of BCR‐ABL mutations. Dasatinib is a 325‐fold more potent inhibitor of Bcr‐Abl than imatinib and has been associated with high rates of durable responses in patients with CML in chronic phase (CP) after imatinib failure. METHODS: To determine the optimal time for initiating dasatinib after loss of response on imatinib, data from dasatinib trials in CML‐CP were analyzed. Patients were grouped according to whether they received early intervention with dasatinib (ie, after cytogenetic recurrence on imatinib), rather than after both cytogenetic and hematologic recurrence. RESULTS: Overall, 72% of patients who received dasatinib after loss of a major cytogenetic response (MCyR) on imatinib achieved a complete cytogenetic response (CCyR) compared with 42% of patients who were treated after loss of both MCyR and complete hematologic response (CHR). Event‐free survival (EFS) also was higher after earlier dasatinib treatment (24‐month EFS rates: 89% after loss of MCyR on imatinib vs 29% after loss of both MCyR and CHR). Among patients who were treated after loss of CHR on imatinib with no prior MCyR, 26% achieved a CCyR with dasatinib, and the 24‐month EFS rate was 64%. In all 3 groups, CCyR rates were similar in patients with or without pre‐existing BCR‐ABL mutations. CONCLUSIONS: The results of the current study suggested that optimal outcomes are achieved when dasatinib is administered early after imatinib resistance. Cancer 2009. © 2009 American Cancer Society." @default.
• W2022158208 created "2016-06-24" @default.
• W2022158208 creator A5000750846 @default.
• W2022158208 creator A5006104041 @default.
• W2022158208 creator A5015140142 @default.
• W2022158208 creator A5019337932 @default.
• W2022158208 creator A5033937088 @default.
• W2022158208 creator A5055045706 @default.
• W2022158208 creator A5068525042 @default.
• W2022158208 creator A5087074127 @default.
• W2022158208 creator A5090435894 @default.
• W2022158208 date "2009-04-28" @default.
• W2022158208 modified "2023-10-12" @default.
• W2022158208 title "Dasatinib early intervention after cytogenetic or hematologic resistance to imatinib in patients with chronic myeloid leukemia" @default.
• W2022158208 cites W1964023655 @default.
• W2022158208 cites W1965553215 @default.
• W2022158208 cites W1970962784 @default.
• W2022158208 cites W1978514731 @default.
• W2022158208 cites W1990020715 @default.
• W2022158208 cites W2001523905 @default.
• W2022158208 cites W2004492241 @default.
• W2022158208 cites W2011474502 @default.
• W2022158208 cites W2015616444 @default.
• W2022158208 cites W2059441519 @default.
• W2022158208 cites W2070067474 @default.
• W2022158208 cites W2070683532 @default.
• W2022158208 cites W2074740152 @default.
• W2022158208 cites W2086344594 @default.
• W2022158208 cites W2097946794 @default.
• W2022158208 cites W2100041900 @default.
• W2022158208 cites W2101390452 @default.
• W2022158208 cites W2107268345 @default.
• W2022158208 cites W2117569938 @default.
• W2022158208 cites W2126235458 @default.
• W2022158208 cites W2129315565 @default.
• W2022158208 cites W2134512113 @default.
• W2022158208 cites W2157743993 @default.
• W2022158208 cites W2164872817 @default.
• W2022158208 cites W2165537263 @default.
• W2022158208 cites W2167087359 @default.
• W2022158208 cites W2170356980 @default.
• W2022158208 cites W2993520909 @default.
• W2022158208 doi "https://doi.org/10.1002/cncr.24325" @default.
• W2022158208 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4176768" @default.
• W2022158208 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19402171" @default.
• W2022158208 hasPublicationYear "2009" @default.
• W2022158208 type Work @default.
• W2022158208 sameAs 2022158208 @default.
• W2022158208 citedByCount "54" @default.
• W2022158208 countsByYear W20221582082012 @default.
• W2022158208 countsByYear W20221582082013 @default.
• W2022158208 countsByYear W20221582082014 @default.
• W2022158208 countsByYear W20221582082015 @default.
• W2022158208 countsByYear W20221582082016 @default.
• W2022158208 countsByYear W20221582082018 @default.
• W2022158208 countsByYear W20221582082020 @default.
• W2022158208 countsByYear W20221582082022 @default.
• W2022158208 crossrefType "journal-article" @default.
• W2022158208 hasAuthorship W2022158208A5000750846 @default.
• W2022158208 hasAuthorship W2022158208A5006104041 @default.
• W2022158208 hasAuthorship W2022158208A5015140142 @default.
• W2022158208 hasAuthorship W2022158208A5019337932 @default.
• W2022158208 hasAuthorship W2022158208A5033937088 @default.
• W2022158208 hasAuthorship W2022158208A5055045706 @default.
• W2022158208 hasAuthorship W2022158208A5068525042 @default.
• W2022158208 hasAuthorship W2022158208A5087074127 @default.
• W2022158208 hasAuthorship W2022158208A5090435894 @default.
• W2022158208 hasBestOaLocation W20221582081 @default.
• W2022158208 hasConcept C121608353 @default.
• W2022158208 hasConcept C126322002 @default.
• W2022158208 hasConcept C143998085 @default.
• W2022158208 hasConcept C2777583451 @default.
• W2022158208 hasConcept C2778729363 @default.
• W2022158208 hasConcept C2778820342 @default.
• W2022158208 hasConcept C2779536868 @default.
• W2022158208 hasConcept C71924100 @default.
• W2022158208 hasConcept C90924648 @default.
• W2022158208 hasConceptScore W2022158208C121608353 @default.
• W2022158208 hasConceptScore W2022158208C126322002 @default.
• W2022158208 hasConceptScore W2022158208C143998085 @default.
• W2022158208 hasConceptScore W2022158208C2777583451 @default.
• W2022158208 hasConceptScore W2022158208C2778729363 @default.
• W2022158208 hasConceptScore W2022158208C2778820342 @default.
• W2022158208 hasConceptScore W2022158208C2779536868 @default.
• W2022158208 hasConceptScore W2022158208C71924100 @default.
• W2022158208 hasConceptScore W2022158208C90924648 @default.
• W2022158208 hasIssue "13" @default.
• W2022158208 hasLocation W20221582081 @default.
• W2022158208 hasLocation W20221582082 @default.
• W2022158208 hasLocation W20221582083 @default.
• W2022158208 hasLocation W20221582084 @default.
• W2022158208 hasOpenAccess W2022158208 @default.
• W2022158208 hasPrimaryLocation W20221582081 @default.
• W2022158208 hasRelatedWork W1963599260 @default.
• W2022158208 hasRelatedWork W1967535809 @default.
• W2022158208 hasRelatedWork W2064607797 @default.
• W2022158208 hasRelatedWork W2120077570 @default.
• W2022158208 hasRelatedWork W2139973222 @default.

• next